Analyst track record

Owen Lau

Oppenheimer. BullRecon tracks source-verified rating actions and evaluates only completed performance windows.

All analysts
Qualified calls
22
Adjusted win rate
+68%
Avg excess return
—
Confidence
medium
Published history

Latest source-verified calls

COIN
Oppenheimer
Outperform
Action
Target Cut
Target
USD370
Jan 12, 2026
CME
Oppenheimer
Outperform
Action
Target Raise
Target
USD303
Jul 24, 2025
MCO
Oppenheimer
Outperform
Action
Target Raise
Target
USD563
Jul 24, 2025
NDAQ
Oppenheimer
Outperform
Action
Target Raise
Target
USD101
Jul 15, 2025
SPGI
Oppenheimer
Outperform
Action
Target Raise
Target
USD592
Jul 2, 2025
MCO
Oppenheimer
Outperform
Action
Target Raise
Target
USD552
Jul 2, 2025
NDAQ
Oppenheimer
Outperform
Action
Target Raise
Target
USD96
Jun 17, 2025
MCO
Oppenheimer
Outperform
Action
Target Raise
Target
USD523
Jun 5, 2025
CME
Oppenheimer
Outperform
Action
Target Raise
Target
USD300
Jun 4, 2025
CME
Oppenheimer
Outperform
Action
Target Raise
Target
USD282
Apr 24, 2025
MCO
Oppenheimer
Outperform
Action
Target Cut
Target
USD489
Apr 23, 2025
CME
Oppenheimer
Outperform
Action
Target Raise
Target
USD279
Apr 11, 2025
NDAQ
Oppenheimer
Outperform
Action
Target Cut
Target
USD85
Apr 11, 2025
CME
Oppenheimer
Outperform
Action
Target Raise
Target
USD269
Feb 13, 2025
NDAQ
Oppenheimer
Outperform
Action
Target Raise
Target
USD89
Jan 13, 2025
SPGI
Oppenheimer
Outperform
Action
Target Cut
Target
USD580
Jan 3, 2025
MCO
Oppenheimer
Outperform
Action
Target Raise
Target
USD545
Jan 3, 2025
NDAQ
Oppenheimer
Outperform
Action
Target Raise
Target
USD86
Oct 25, 2024
CME
Oppenheimer
Outperform
Action
Target Raise
Target
USD258
Oct 24, 2024
MCO
Oppenheimer
Outperform
Action
Target Raise
Target
USD543
Oct 23, 2024
CME
Oppenheimer
Outperform
Action
Target Raise
Target
USD245
Oct 14, 2024
NDAQ
Oppenheimer
Outperform
Action
Target Raise
Target
USD84
Oct 14, 2024

The 126-session metric starts from the first completed session after each public call and subtracts SPY performance over the same window. Historical results are not investment advice.